<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="T3" position="float">
 <label>TABLE 3</label>
 <caption>
  <p>Plant derivatives with potential effect on the Spike-RBD/TMPRSS2/ACE2 axis.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead valign="top">
   <tr>
    <th align="left" rowspan="1" colspan="1">Target</th>
    <th align="center" rowspan="1" colspan="1">Plant (bioactive phytoconstituent/product)</th>
    <th align="center" rowspan="1" colspan="1">Study type</th>
    <th align="center" rowspan="1" colspan="1">Efficacious dose(s)</th>
    <th align="center" rowspan="1" colspan="1">Biological test</th>
    <th align="center" rowspan="1" colspan="1">Mechanistic effect</th>
    <th align="center" rowspan="1" colspan="1">Findings</th>
    <th align="center" rowspan="1" colspan="1">References</th>
    <th align="center" rowspan="1" colspan="1">Comment</th>
   </tr>
  </thead>
  <tbody valign="top">
   <tr>
    <td rowspan="12" align="left" colspan="1">Interfere with ACE2 activity</td>
    <td align="left" rowspan="1" colspan="1">
     <italic>Nicotiana benthamiana</italic> domin (recombinant RBD)
    </td>
    <td align="left" rowspan="1" colspan="1">
     <italic>In silico and In vitro</italic> (vero E6 cells)
    </td>
    <td align="left" rowspan="1" colspan="1">NA</td>
    <td align="left" rowspan="1" colspan="1">Recombinant mAb RBD production in a plant expression system. Neutralization efficiency against positive sera</td>
    <td align="left" rowspan="1" colspan="1">Binds to ACE2</td>
    <td align="left" rowspan="1" colspan="1">Specific binding to the SARS-CoV-2 receptor and its neutralization</td>
    <td align="left" rowspan="1" colspan="1">
     <xref rid="B97" ref-type="bibr">Rattanapisit et al. (2020)</xref>
    </td>
    <td align="left" rowspan="1" colspan="1">Suggested consideration of this plant derived recombinant RBD for the development of vaccines and viral detection/diagnostic reagents</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>Pelargonium graveolens</italic> L'Hér. (Citronellol) and 
     <italic>Citrus × limon</italic> (L.) osbeck (Limonene)
     <xref ref-type="table-fn" rid="Tfn1">
      <sup>a</sup>
     </xref>
    </td>
    <td align="left" rowspan="1" colspan="1">
     <italic>In vitro</italic> (HT-29 cell line)
    </td>
    <td align="left" rowspan="1" colspan="1">50 μg/ml geranium oil and 25 μg/ml lemon oil</td>
    <td align="left" rowspan="1" colspan="1">Gene expression profile (mRNA and protein)</td>
    <td align="left" rowspan="1" colspan="1">Downregulates the expression of ACE2 and TMPRSS2</td>
    <td align="left" rowspan="1" colspan="1">Significant inhibition of ACE2 and TMPRSS2 in epithelial cells to protect against SARS-CoV-2 invasion</td>
    <td align="left" rowspan="1" colspan="1">
     <xref rid="B100" ref-type="bibr">Senthil Kumar et al. (2020)</xref>
    </td>
    <td align="left" rowspan="1" colspan="1">Citronellol and limonene were the most potent of eight ACE2 inhibitory oil extracts and had dose dependent effects</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>Momordica dioica</italic> roxb. ex willd (catechin, quercetin, hederagenin and oleanolic acid)
    </td>
    <td align="left" rowspan="1" colspan="1">
     <italic>In silico and In vitro</italic>
    </td>
    <td align="left" rowspan="1" colspan="1">NA</td>
    <td align="left" rowspan="1" colspan="1">Molecular docking and 
     <italic>in silico</italic> ADME predictions methods
    </td>
    <td align="left" rowspan="1" colspan="1">Docking to ACE2</td>
    <td align="left" rowspan="1" colspan="1">The constituent bioactive flavonoids (catechin and quercetin) and triterpenoids (hederagenin and oleanolic acid) inhibit ACE2 and DPP4 receptors</td>
    <td align="left" rowspan="1" colspan="1">
     <xref rid="B99" ref-type="bibr">Sakshi et al. (2021)</xref>
    </td>
    <td align="left" rowspan="1" colspan="1">Constituent flavonoids have better affinities than standard remdesivir, favipiravir and hydroxychloroquine</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>Valeriana jatamansi</italic> jones ex roxb. (Hesperidin), 
     <italic>Oroxylum indicum</italic> (L.) kurz (chrysin), 
     <italic>Rheum australe</italic> D.Don (emodin)
    </td>
    <td align="left" rowspan="1" colspan="1">
     <italic>In silico</italic>
    </td>
    <td align="left" rowspan="1" colspan="1">NA</td>
    <td align="left" rowspan="1" colspan="1">Molecular docking and molecular dynamics</td>
    <td align="left" rowspan="1" colspan="1">Allosterically binds to ACE2 and can also destabilize spike-ACE2 interaction</td>
    <td align="left" rowspan="1" colspan="1">Ligands (especially hesperidin) triggers conformational changes that causes spike-ACE2 fragment to be unstable</td>
    <td align="left" rowspan="1" colspan="1">
     <xref rid="B5" ref-type="bibr">Basu et al. (2020)</xref>
    </td>
    <td align="left" rowspan="1" colspan="1">Spike inhibitory capacity similar to that of docked chloroquine and hydroxychloroquine</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>Artemisia absinthium</italic> L. (anabsinthin, absinthin, dicaffeoylquinic acids), 
     <italic>Syzygium aromaticum</italic> (L.) merr. and L.M.Perry (3-0-caffeoylquinic), 
     <italic>Phaseolus vulgaris</italic> L. (quercetin 3-glucuronide-7-glucoside, quercetin 3-vicianoside, isosakuranetin 7-O-neohesperidoside) and 
     <italic>Inula helenium</italic> L. (Quercetin-7-O-galactoside, 3,5-dicaffeoylquinic acid, 3,4,5-tricaffeoylquinic acid)
    </td>
    <td align="left" rowspan="1" colspan="1">
     <italic>In silico</italic>
    </td>
    <td align="left" rowspan="1" colspan="1">NA</td>
    <td align="left" rowspan="1" colspan="1">Molecular modeling/docking and dynamic simulations</td>
    <td align="left" rowspan="1" colspan="1">High affinity binding to pocket of the active site of ACE2</td>
    <td align="left" rowspan="1" colspan="1">Ligands could inhibit viral fusion</td>
    <td align="left" rowspan="1" colspan="1">
     <xref rid="B55" ref-type="bibr">Joshi et al. (2020)</xref>
    </td>
    <td align="left" rowspan="1" colspan="1">Compounds demonstrated good intestinal and brain permeability. Also showed no carcinogenic tendency</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>Allium sativum</italic> L. (diallyl tetrasulfide and trisulfide, 2-propenyl propyl)
     <xref ref-type="table-fn" rid="Tfn1">
      <sup>a</sup>
     </xref>
    </td>
    <td align="left" rowspan="1" colspan="1">
     <italic>In silico</italic>
    </td>
    <td align="left" rowspan="1" colspan="1">N/A</td>
    <td align="left" rowspan="1" colspan="1">Molecular modeling/docking</td>
    <td align="left" rowspan="1" colspan="1">Binds to ACE2 receptor</td>
    <td align="left" rowspan="1" colspan="1">Could inhibit viral entry and infectivity</td>
    <td align="left" rowspan="1" colspan="1">
     <xref rid="B112" ref-type="bibr">Thuy et al. (2020)</xref>
    </td>
    <td align="left" rowspan="1" colspan="1">Ligands are the two most potent of seventeen inhibitors of ACE2 gotten from essential oil of plant</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>Piper</italic> sp
     <italic>.</italic> (pipercyclobutanamide B, a and nigramide Q) like 
     <italic>Piper nigrum</italic> L. and 
     <italic>Piper retrofractum</italic> vahl
    </td>
    <td align="left" rowspan="1" colspan="1">
     <italic>In silico</italic>
    </td>
    <td align="left" rowspan="1" colspan="1">NA</td>
    <td align="left" rowspan="1" colspan="1">Molecular modeling/docking and dynamic simulations</td>
    <td align="left" rowspan="1" colspan="1">Docks closely to active site of ACE2</td>
    <td align="left" rowspan="1" colspan="1">These dimeric piperamides of essential oil could possibly inhibit ACE2 mediated entry of SARS CoV2</td>
    <td align="left" rowspan="1" colspan="1">
     <xref rid="B42" ref-type="bibr">Gutierrez-Villagomez et al. (2020)</xref>
    </td>
    <td align="left" rowspan="1" colspan="1">Exhibit potential drug likeness based on ADME. Pipercyclobutanamide B (most potent) docked along duct to ACE2 active site</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>Ipomoea obscura</italic> (L.) ker gawl. (Urso-deoxycholic acid)
     <xref ref-type="table-fn" rid="Tfn1">
      <sup>a</sup>
     </xref>
    </td>
    <td align="left" rowspan="1" colspan="1">
     <italic>In silico</italic>
    </td>
    <td align="left" rowspan="1" colspan="1">N/A</td>
    <td align="left" rowspan="1" colspan="1">Molecular modeling/docking</td>
    <td align="left" rowspan="1" colspan="1">Bind to ACE2 receptor</td>
    <td align="left" rowspan="1" colspan="1">Could inhibit viral entry and infectivity</td>
    <td align="left" rowspan="1" colspan="1">
     <xref rid="B95" ref-type="bibr">Poochi et al. (2020)</xref>
    </td>
    <td align="left" rowspan="1" colspan="1">This is the most potent of five possibly bioactive ACE2 inhibitors from ethanolic extract of the plant</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>Ammoides verticillata</italic> (desf.) briq. -From Algeria (isothymol)
    </td>
    <td align="left" rowspan="1" colspan="1">
     <italic>In silico</italic>
    </td>
    <td align="left" rowspan="1" colspan="1">NA</td>
    <td align="left" rowspan="1" colspan="1">Molecular modeling/docking</td>
    <td align="left" rowspan="1" colspan="1">Binds to ACE2 receptor</td>
    <td align="left" rowspan="1" colspan="1">High affinity and can inhibit ACE2 better than captopril and chloroquine drugs</td>
    <td align="left" rowspan="1" colspan="1">
     <xref rid="B1" ref-type="bibr">Abdelli et al. (2020)</xref>
    </td>
    <td align="left" rowspan="1" colspan="1">Suggest oil is one of the richest natural sources of isothymol. Good ADMET</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>Melaleuca cajuputi</italic> maton &amp; sm. ex R. Powell (terpineol, guaiol and linalool)
     <xref ref-type="table-fn" rid="Tfn1">
      <sup>a</sup>
     </xref>
    </td>
    <td align="left" rowspan="1" colspan="1">
     <italic>In silico</italic>
    </td>
    <td align="left" rowspan="1" colspan="1">NA</td>
    <td align="left" rowspan="1" colspan="1">Molecular modeling/docking and dynamic simulations</td>
    <td align="left" rowspan="1" colspan="1">Latch to the active site of ACE2</td>
    <td align="left" rowspan="1" colspan="1">Lots of convergence points and the inhibitory intensity of these compounds on ACE2 could prevent viral invasion</td>
    <td align="left" rowspan="1" colspan="1">
     <xref rid="B81" ref-type="bibr">My et al. (2020)</xref>
    </td>
    <td align="left" rowspan="1" colspan="1">Out of ten inhibitory substances, these three have the most potent effect on ACE2. Guaiol is also present in guaiacum and cypress pine oils</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>Scutellaria baicalensis</italic> georgi (baicalin), 
     <italic>Erigeron breviscapus</italic> (vaniot) hand-mazz. (Scutellarin), 
     <italic>Citrus × aurantium</italic> L. 
     <italic>and Citrus reticulata</italic> blanco (hesperetin), liquorice; 
     <italic>Glycyrrhiza uralensis</italic> fisch. ex DC. (glycyrrhizin) and soybean; 
     <italic>Glycine</italic> max (L.) merr. (Nicotianamine)
    </td>
    <td align="left" rowspan="1" colspan="1">
     <italic>In silico</italic>
    </td>
    <td align="left" rowspan="1" colspan="1">NA</td>
    <td align="left" rowspan="1" colspan="1">Molecular modeling/docking and dynamic simulations</td>
    <td align="left" rowspan="1" colspan="1">Latch to the active site of ACE2</td>
    <td align="left" rowspan="1" colspan="1">Potential to bind ACE2 and hinder viral entry</td>
    <td align="left" rowspan="1" colspan="1">
     <xref rid="B14" ref-type="bibr">Chen and Du (2020)</xref>
    </td>
    <td align="left" rowspan="1" colspan="1">Nicotianamine is “soybean ACE2 inhibitor” (ACE2iSB)</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Gancao
     <italic>: Glycyrrhiza</italic> spp. and chaihu
     <italic>: Bupleurum</italic> spp. (glyasperin F and isorhamnetin)
    </td>
    <td align="left" rowspan="1" colspan="1">
     <italic>In silico</italic>
    </td>
    <td align="left" rowspan="1" colspan="1">NA</td>
    <td align="left" rowspan="1" colspan="1">Molecular docking</td>
    <td align="left" rowspan="1" colspan="1">Bind to ACE2</td>
    <td align="left" rowspan="1" colspan="1">Latch onto site 1 and site 2 of ACE2</td>
    <td align="left" rowspan="1" colspan="1">
     <xref rid="B98" ref-type="bibr">Ren et al. (2020)</xref>
    </td>
    <td align="left" rowspan="1" colspan="1">Suggest the ligands, glyasperin F and isorhamnetin, account for strong binding affinity</td>
   </tr>
   <tr>
    <td rowspan="4" align="left" colspan="1">Interface with the viral spike glycoprotein and its RBD</td>
    <td align="left" rowspan="1" colspan="1">Liquorice; 
     <italic>Glycyrrhiza glabra</italic> L
     <italic>.</italic> (glycyrrhizic acid)
    </td>
    <td align="left" rowspan="1" colspan="1">
     <italic>In silico</italic>
    </td>
    <td align="left" rowspan="1" colspan="1">NA</td>
    <td align="left" rowspan="1" colspan="1">Molecular modeling/docking and dynamic simulations</td>
    <td align="left" rowspan="1" colspan="1">Bind to cavity of prefusion spike glycoprotein</td>
    <td align="left" rowspan="1" colspan="1">High binding affinity to spike protein may block viral fusion to ACE2</td>
    <td align="left" rowspan="1" colspan="1">
     <xref rid="B106" ref-type="bibr">Sinha et al. (2020a)</xref>
    </td>
    <td align="left" rowspan="1" colspan="1">High protein-ligand stability. Most potent of six interactive ligands</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>Bupleurum</italic> spp.
     <italic>, Heteromorpha</italic> spp. 
     <italic>and Scrophularia scorodonia</italic> L
     <italic>.</italic> (saikosaponins U and V)
     <xref ref-type="table-fn" rid="Tfn1">
      <sup>a</sup>
     </xref>
    </td>
    <td align="left" rowspan="1" colspan="1">
     <italic>In silico</italic>
    </td>
    <td align="left" rowspan="1" colspan="1">NA</td>
    <td align="left" rowspan="1" colspan="1">Molecular modeling/docking and dynamic simulations</td>
    <td align="left" rowspan="1" colspan="1">Binds to RBD and cleavage site of the spike glycoprotein</td>
    <td align="left" rowspan="1" colspan="1">May inhibit viral entry by interfering with virion-receptor binding and protease cleavage</td>
    <td align="left" rowspan="1" colspan="1">
     <xref rid="B107" ref-type="bibr">Sinha et al. (2020b)</xref>
    </td>
    <td align="left" rowspan="1" colspan="1">Out of 23 saikosaponins, had the most potent latching affinity to active site of spike glycoprotein (i.e. RBD)</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Indian ginseng: 
     <italic>Withania somnifera</italic> (L.) dunal (withanoside X and quercetin glucoside)
     <xref ref-type="table-fn" rid="Tfn1">
      <sup>a</sup>
     </xref>
    </td>
    <td align="left" rowspan="1" colspan="1">
     <italic>In silico</italic>
    </td>
    <td align="left" rowspan="1" colspan="1">NA</td>
    <td align="left" rowspan="1" colspan="1">Molecular modeling/docking and dynamic simulations</td>
    <td align="left" rowspan="1" colspan="1">Binds receptor binding domain of prefusion spike protein from SARS-CoV-2</td>
    <td align="left" rowspan="1" colspan="1">Favourable interaction with receptor binding motif (RBM) of RBD to block viral fusion</td>
    <td align="left" rowspan="1" colspan="1">
     <xref rid="B21" ref-type="bibr">Chikhale et al. (2020a)</xref>
    </td>
    <td align="left" rowspan="1" colspan="1">Ligands were potent (out of 17) inhibitors of SARS-CoV-2 spike glycoprotein</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>Asparagus racemosus</italic> willd. (Asparoside D and C)
    </td>
    <td align="left" rowspan="1" colspan="1">
     <italic>In silico</italic>
    </td>
    <td align="left" rowspan="1" colspan="1">NA</td>
    <td align="left" rowspan="1" colspan="1">Molecular modeling/docking and dynamic simulations</td>
    <td align="left" rowspan="1" colspan="1">Bind to spike RBD</td>
    <td align="left" rowspan="1" colspan="1">Good affinity and stable docking of spike RBD</td>
    <td align="left" rowspan="1" colspan="1">
     <xref rid="B22" ref-type="bibr">Chikhale et al. (2020b)</xref>
    </td>
    <td align="left" rowspan="1" colspan="1">Higher binding affinity than remdesivir (standard drug)</td>
   </tr>
   <tr>
    <td rowspan="4" align="left" colspan="1">Interrupting the spike-rbd/ace2 interaction</td>
    <td align="left" rowspan="1" colspan="1">
     <italic>Withania somnifera</italic> (L.) dunal (withanone)
    </td>
    <td align="left" rowspan="1" colspan="1">
     <italic>In silico</italic>
    </td>
    <td align="left" rowspan="1" colspan="1">NA</td>
    <td align="left" rowspan="1" colspan="1">Molecular modeling/docking</td>
    <td align="left" rowspan="1" colspan="1">Interrupts at the junction between ACE2 receptor and viral S-RBD</td>
    <td align="left" rowspan="1" colspan="1">Decreased binding free energies, destabilized salt bridges, hence blocks and weaken SARS CoV2 entry and infectivity</td>
    <td align="left" rowspan="1" colspan="1">
     <xref rid="B4" ref-type="bibr">Balkrishna et al. (2020)</xref>
    </td>
    <td align="left" rowspan="1" colspan="1">Suggest plant as first choice herb in curbing COVID-19</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>Diplocyclos palmatus</italic> (L.) leaf extract (ripladib)
    </td>
    <td align="left" rowspan="1" colspan="1">
     <italic>In silico</italic>
    </td>
    <td align="left" rowspan="1" colspan="1">NA</td>
    <td align="left" rowspan="1" colspan="1">Molecular modeling/docking</td>
    <td align="left" rowspan="1" colspan="1">Interrupts at the RBD of Spike-ACE2 complex</td>
    <td align="left" rowspan="1" colspan="1">Predicted strong binding at RBD interface to block Spike-ACE2 interactions and viral entry</td>
    <td align="left" rowspan="1" colspan="1">
     <xref rid="B3" ref-type="bibr">Alexpandi et al. (2020)</xref>
    </td>
    <td align="left" rowspan="1" colspan="1">ADMET analysis indicate good pharmacokinetic properties</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>Citrus</italic> spp. (hesperidin)
    </td>
    <td align="left" rowspan="1" colspan="1">
     <italic>In silico</italic>
    </td>
    <td align="left" rowspan="1" colspan="1">NA</td>
    <td align="left" rowspan="1" colspan="1">Molecular modeling/docking</td>
    <td align="left" rowspan="1" colspan="1">Binds to both RBD and ACE2 receptor</td>
    <td align="left" rowspan="1" colspan="1">The flavonoid can possibly interrupt RBD/ACE2 interface to abrogate entry</td>
    <td align="left" rowspan="1" colspan="1">
     <xref rid="B118" ref-type="bibr">Utomo et al. (2020)</xref>
    </td>
    <td align="left" rowspan="1" colspan="1">The peel of Citrus sp. represents the most abundant methoxy flavonoid (hesperidin) store of the plant</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Grape skin: 
     <italic>Vitis vinifera</italic> L. (resveratrol)
    </td>
    <td align="left" rowspan="1" colspan="1">
     <italic>In silico</italic>
    </td>
    <td align="left" rowspan="1" colspan="1">NA</td>
    <td align="left" rowspan="1" colspan="1">Molecular modeling/docking and dynamic simulations</td>
    <td align="left" rowspan="1" colspan="1">Bind tightly and interfere with viral S protein/ACE2 receptor complex</td>
    <td align="left" rowspan="1" colspan="1">Highly stable binding and selectivity to viral protein/ACE2 receptor complex. Disrupts the spike protein</td>
    <td align="left" rowspan="1" colspan="1">
     <xref rid="B121" ref-type="bibr">Wahedi et al. (2020)</xref>
    </td>
    <td align="left" rowspan="1" colspan="1">Most potent of four stilbene-based natural compounds</td>
   </tr>
   <tr>
    <td rowspan="2" align="left" colspan="1">Interfere with the host membrane protease</td>
    <td align="left" rowspan="1" colspan="1">
     <italic>Aframomum melegueta</italic> K.Schum. (quercetin, apigenin)
    </td>
    <td align="left" rowspan="1" colspan="1">
     <italic>In silico and In vitro</italic>
    </td>
    <td align="left" rowspan="1" colspan="1">30, 10, 3, 1, 0.3 mg/L. From fruit (with seed)</td>
    <td align="left" rowspan="1" colspan="1">Docking. 
     <italic>In vitro</italic> inhibition of recombinant soluble human furin. Immuno-blotting
    </td>
    <td align="left" rowspan="1" colspan="1">Disrupts spike glycoprotein/receptor interaction by inhibiting furin cleavage</td>
    <td align="left" rowspan="1" colspan="1">Metabolites inhibited furin dependent pre-glycoprotein processing by possibly blocking furin recognition site</td>
    <td align="left" rowspan="1" colspan="1">
     <xref rid="B90" ref-type="bibr">Omotuyi et al. (2020)</xref>
    </td>
    <td align="left" rowspan="1" colspan="1">Suggested bioactive influence of flavonoids (like quercetin, apigenin). Good ADMET sores</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">
     <italic>Withania somnifera</italic> (L.) dunal (withanone and Withaferine-A)
    </td>
    <td align="left" rowspan="1" colspan="1">
     <italic>In silico</italic>
    </td>
    <td align="left" rowspan="1" colspan="1">NA</td>
    <td align="left" rowspan="1" colspan="1">Molecular modeling/docking</td>
    <td align="left" rowspan="1" colspan="1">Binds to TMPRSS2 catalytic site (Wi-N &gt; Wi-A), alters allosteric site and also downregulates TMPRSS2 transcription</td>
    <td align="left" rowspan="1" colspan="1">Predicted multiple action in blocking SARS CoV2 cell entry and propagation by inhibiting TMPRSS2</td>
    <td align="left" rowspan="1" colspan="1">
     <xref rid="B61" ref-type="bibr">Kumar et al. (2020c)</xref>
    </td>
    <td align="left" rowspan="1" colspan="1">Possible drug-able agents for prevention and therapeutics</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn id="Tfn1">
   <label>a</label>
   <p>These compounds were found to be the most potent of several others.</p>
  </fn>
  <fn>
   <p>
    <bold>Abbreviations:</bold> ACE2, Angiotensin converting enzyme two; ADME/T, Absorption, Distribution, Metabolism, Excretion/and Toxicity; DPP4, Dipeptidyl peptidase four; mAb, monoclonal antibody; NA, not available; PK, Pharmacokinetic; S-RBD, Spike glycoprotein receptor binding domain; TMPRSS2, Transmembrane protease serine two; Wi-A, Withaferine-A; Wi-N, Withanone.
   </p>
  </fn>
 </table-wrap-foot>
</table-wrap>
